Organic modifier and adjuvant in hepatic metabolic disorders.
Indications for Use
Hepatic and renal impairment. Lead, mercury and arsenic poisoning. Food poisoning. Mushroom poisoning (Amanita spp.). Asthenia. Urticaria and other skin conditions. Precomatose states and hepatic coma.
Route of Administration
Subcutaneous, intramuscular or slow intravenous.
Dosage and Instructions for Use
Dogs: 2 to 3 mg/kg live weight (0.4 to 0.6 ml/kg live weight) daily, administered SC, IM or slow IV, in series of 5 to 10 days. Cats: 1 to 1.5 mg/kg live weight (0.2 to 0.3 ml/kg live weight) daily, administered SC, IM or slow IV, in series of 5 to 10 days. Horses: 0.5 mg/kg live weight (10 ml/kg 100 live weight) daily, administered SC, IM or slow IV, in series of 5 to 10 days. Dosage may vary at the discretion of the intervening Veterinary Surgeon.